Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementi...

par Deepthi Yedlapudi, Liping Xu, Dan Luo, Gregory B. Marsh, Sokol V. Todi, Aloke K. Dutta
Publié 2019

Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of Spinocerebellar Ataxia Type 3

par Sean L. Johnson, Kozeta Libohova, Jessica R. Blount, Alyson L. Sujkowski, Matthew V. Prifti, Wei-Ling Tsou, Sokol V. Todi
Publié 2021